1. Manolis, T.A., A.A. Manolis, and A.S. Manolis, Cardiovascular Safety of Psychiatric Agents: A Cautionary Tale. Angiology, 2019. 70(2): p. 103-129.
2. Ciumărnean, L., , Cardiovascular Risk Factors and Physical Activity for the Prevention of Cardiovascular Diseases in the Elderly. Int J Environ Res Public Health, 2021. 19(1).
3. Molina, J.D., , Metabolomic Connections between Schizophrenia, Antipsychotic Drugs and Metabolic Syndrome: A Variety of Players. Curr Pharm Des, 2021. 27(39): p. 4049-4061.
4. Edinoff, A., , Cariprazine to Treat Schizophrenia and Bipolar Disorder in Adults. Psychopharmacol Bull, 2020. 50(4): p. 83-117.
5. Remington, G., , Guidelines for the Pharmacotherapy of Schizophrenia in Adults. Can J Psychiatry, 2017. 62(9): p. 604-616.